Does SPECT/CT Imaging Paired with Clinical Evaluation Provide Prognostic Utility for Short-term Outcomes of Targeted Interventions for Chronic Axial Spine Pain? An Exploratory Study
Keywords:bisphosphonate, SPECT/CT, facet, zygapophyseal, targeted, injection
To determine short-term pain outcomes associated with targeted intervention, guided by a concordant clinical evaluation and Tc-99m methylenediphosphonate SPECT/CT bone scan findings in patients with chronic recalcitrant axial spine pain.
Medical records were reviewed of consecutive patients who underwent SPECT/CT as part of their evaluation between April, 2007 and August, 2012. Corticosteroid injection or radiofrequency ablation (RFA) was performed based on concordance between clinical evaluation and SPECT/CT findings. The primary outcome was the proportion of patients with >50% pain reduction at >4 weeks after the intervention.
Of 98 patients who underwent SPECT/CT, 77 (79%) underwent targeted intervention. A responder rate (>50% pain relief) of 50% (95% CI 35-65%) and 60% (95% CI 35-85%) for facet and non-facet axial spinal corticosteroid injections >4 weeks post-intervention, respectively, was observed. MBN RFA demonstrated a responder rate (>80% pain relief) of 78% (95% CI 59-97%) at least 4 weeks post-treatment; 67% (95% CI 45-88%) of patients who underwent MBN RFA following this selection protocol reported 100% pain relief at least 4 weeks post treatment.
In this single center retrospective study, SPECT/CT interpreted in the context of the clinical evaluation provided value as a prognostic tool for targeted interventions in patients with chronic, axial spine pain. However, prospective, multi-center study with long-term outcome assessment including defining means of quantifying clinically meaningful SPECT/CT findings is needed.
Published articles are:
- Peer reviewed
- Immediately and permanently free for everyone to read and download
- Permanently preserved in our online archive
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material
You have to follow these terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- Noncommercial — You may not use the material for commercial purposes.